Lexanopadol
| Lexanopadol_structure.png | |
Lexanopadol is a novel analgesic drug that acts as a mixed opioid receptor agonist and norepinephrine reuptake inhibitor. It is being investigated for its potential use in the management of moderate to severe pain. Lexanopadol is unique in its dual mechanism of action, which may offer advantages over traditional opioid analgesics by providing effective pain relief with a potentially lower risk of side effects such as opioid-induced hyperalgesia and opioid use disorder.
Pharmacology[edit | edit source]
Lexanopadol exhibits its analgesic effects primarily through its action on the mu-opioid receptor (MOR) and the delta-opioid receptor (DOR). It acts as a partial agonist at these receptors, which contributes to its pain-relieving properties. Additionally, Lexanopadol inhibits the reuptake of norepinephrine, a neurotransmitter involved in the modulation of pain pathways in the central nervous system. This dual action is thought to enhance its analgesic efficacy while potentially reducing the risk of tolerance and dependence associated with pure opioid agonists.
Mechanism of Action[edit | edit source]
The mechanism of action of Lexanopadol involves:
- Mu-opioid receptor agonism: Activation of MOR leads to analgesia by inhibiting the transmission of pain signals in the central nervous system.
- Delta-opioid receptor agonism: Activation of DOR may contribute to analgesia and has been associated with mood enhancement, which can be beneficial in chronic pain management.
- Norepinephrine reuptake inhibition: By preventing the reuptake of norepinephrine, Lexanopadol increases the availability of this neurotransmitter in the synaptic cleft, enhancing its role in pain modulation and potentially improving mood and alertness.
Clinical Trials[edit | edit source]
Lexanopadol is currently undergoing clinical trials to evaluate its safety, efficacy, and tolerability in patients with various types of pain, including chronic pain, neuropathic pain, and postoperative pain. Preliminary results have shown promise, with patients reporting significant pain relief and a favorable side effect profile compared to traditional opioids.
Side Effects[edit | edit source]
Common side effects of Lexanopadol may include:
- Nausea
- Dizziness
- Constipation
- Somnolence
These side effects are generally mild to moderate in severity. The risk of serious adverse effects such as respiratory depression is believed to be lower with Lexanopadol compared to full opioid agonists.
Regulatory Status[edit | edit source]
As of the latest update, Lexanopadol is not yet approved for clinical use and remains an investigational drug. It is being developed by pharmaceutical companies with the aim of providing a safer alternative to existing opioid medications.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
